Nitric Oxide Synthase Gene Transfer as a Tool to Study Biology of Endothelial Cells

During the past decade, the development of gene transfer technology provided a powerful and facile tool that afforded the genetic modification of vascular endothelial function. This development has coincided with molecular cloning and extensive accumulation of knowledge concerning the role of nitric oxide synthase isoforms in vascular homeostasis. Experimental evidence continues to accumulate that in vivo adenovirus-mediated gene transfer into the vessel wall is a very useful technique in studies designed to characterize function of a given gene or protein. In this review, we will use nitric oxide synthase gene transfer as a paradigm to illustrate how gene transfer technology can be used to address key issues in the vascular biology of endothelium. (Arterioscler Thromb Vasc Biol. 2003;23:1990-1994.)

[1]  G. Madhavan.  The Dictionary of Gene Technology: Genomics, Transcriptomics, Proteomics , 2005, Annals of Biomedical Engineering.

[2]  L. d’Uscio,et al.  Inhibitory effect of recombinant iNOS gene expression on vasomotor function of canine basilar artery. , 2002, American Journal of Physiology. Heart and Circulatory Physiology.

[3]  D. Dichek,et al.  Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. D. Rudic,et al.  Functional Reconstitution of Endothelial Nitric Oxide Synthase Reveals the Importance of Serine 1179 in Endothelium-Dependent Vasomotion , 2002, Circulation research.

[5]  R. Parks,et al.  Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapy. , 2002, Current gene therapy.

[6]  T. Billiar,et al.  Inducible Nitric Oxide Synthase: From Cloning to Therapeutic Applications , 2002, World Journal of Surgery.

[7]  W. Sessa,et al.  Expression and Function of Recombinant S1179D Endothelial Nitric Oxide Synthase in Canine Cerebral Arteries , 2002, Stroke.

[8]  S. Dimmeler,et al.  Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. , 2001, The Journal of clinical investigation.

[9]  A. Zeiher,et al.  Aging Enhances the Sensitivity of Endothelial Cells Toward Apoptotic Stimuli: Important Role of Nitric Oxide , 2001, Circulation research.

[10]  J. Mehta,et al.  Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation. , 2001, Cardiovascular research.

[11]  S. Kochanek,et al.  High-capacity 'gutless' adenoviral vectors. , 2001, Current opinion in molecular therapeutics.

[12]  Z. Katusic.  Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? , 2001, American journal of physiology. Heart and circulatory physiology.

[13]  R. Brooks,et al.  NO-Dependent Vasorelaxation Is Impaired After Gene Transfer of Inducible NO-Synthase , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[14]  J. Loscalzo.  Inducible NO synthesis in the vasculature: molecular context defines physiological response. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[15]  J. Astern,et al.  Genetic Deficiency of Inducible Nitric Oxide Synthase Reduces Atherosclerosis and Lowers Plasma Lipid Peroxides in Apolipoprotein E–Knockout Mice , 2001, Circulation.

[16]  H. E. von der Leyen,et al.  Therapeutic potential of nitric oxide synthase gene manipulation. , 2001, Circulation.

[17]  E. Chavakis,et al.  Oxidized LDL Inhibits Vascular Endothelial Growth Factor-Induced Endothelial Cell Migration by an Inhibitory Effect on the Akt/Endothelial Nitric Oxide Synthase Pathway , 2001, Circulation.

[18]  P. Huang,et al.  Mouse models of nitric oxide synthase deficiency. , 2000, Journal of the American Society of Nephrology : JASN.

[19]  D. Rader,et al.  Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice , 2000, The Journal of Immunology.

[20]  R. D. Rudic,et al.  Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. , 2000, The Journal of clinical investigation.

[21]  Z. Katušić,et al.  In vivo gene transfer of endothelial nitric oxide synthase to carotid arteries from hypercholesterolemic rabbits enhances endothelium-dependent relaxations. , 2000, Stroke.

[22]  D. Heistad,et al.  Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits. , 2000, Circulation.

[23]  Z. Katušić,et al.  Gene transfer of endothelial nitric oxide synthase alters endothelium-dependent relaxations in aortas from diabetic rabbits , 2000, Diabetologia.

[24]  S. Rafii,et al.  Induction of Endogenous Genes following Infection of Human Endothelial Cells with an E1− E4+Adenovirus Gene Transfer Vector , 1999, Journal of Virology.

[25]  D. Dichek,et al.  A mouse model of arterial gene transfer: antigen-specific immunity is a minor determinant of the early loss of adenovirus-mediated transgene expression. , 1999, Circulation research.

[26]  K. Channon,et al.  Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. , 1999, Circulation.

[27]  R. Busse,et al.  Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.

[28]  W. Sessa,et al.  Regulation of endothelium-derived nitric oxide production by the protein kinase Akt , 1999, Nature.

[29]  J. Stamler,et al.  In vivo gene transfer of nitric oxide synthase enhances vasomotor function in carotid arteries from normal and cholesterol-Fed rabbits. , 1998, Circulation.

[30]  I. Kullo,et al.  Enhanced endothelium-dependent relaxations after gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries. , 1997, Hypertension.

[31]  H. Zhou,et al.  Adenovirus vector-infected cells can escape adenovirus antigen-specific cytotoxic T-lymphocyte killing in vivo , 1997, Journal of virology.

[32]  M. Mehtali,et al.  Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression , 1997, Gene Therapy.

[33]  James M. Wilson,et al.  Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs , 1996, Journal of virology.

[34]  R. Kelly,et al.  Glucocorticoids Regulate Inducible Nitric Oxide Synthase by Inhibiting Tetrahydrobiopterin Synthesis and L-Arginine Transport* , 1996, The Journal of Biological Chemistry.

[35]  D. Collen,et al.  Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. , 1996, The Journal of clinical investigation.

[36]  J. Leiden,et al.  Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectors , 1996, Nature Medicine.

[37]  P. Libby,et al.  Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. , 1995, The Journal of clinical investigation.

[38]  R. Virmani,et al.  Endothelium-specific in vivo gene transfer. , 1995, Circulation research.

[39]  Y. Kaneda,et al.  Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Virmani,et al.  In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. , 1993, Circulation research.

[41]  E. Nabel,et al.  Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo , 1993, Nature.

[42]  E. Nabel,et al.  Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo. , 1993, The Journal of clinical investigation.

[43]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[44]  D. Dichek,et al.  Enhancement of the fibrinolytic activity of sheep endothelial cells by retroviral vector-mediated gene transfer. , 1991, Blood.

[45]  E. Nabel,et al.  Site-specific gene expression in vivo by direct gene transfer into the arterial wall. , 1990, Science.

[46]  D. Dichek,et al.  Seeding of intravascular stents with genetically engineered endothelial cells. , 1989, Circulation.

[47]  E. Nabel,et al.  Recombinant gene expression in vivo within endothelial cells of the arterial wall. , 1989, Science.

[48]  P. Kantoff,et al.  High-level recombinant gene expression in rabbit endothelial cells transduced by retroviral vectors. , 1989, Science.

[49]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[50]  Luigi Naldini,et al.  Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics , 2001, Nature Medicine.

[51]  U. Förstermann,et al.  Regulation of the Expression of Nitric Oxide Synthase Isoforms , 2000 .

[52]  B. Masters.  Structural Variations to Accommodate Functional Themes of the Isoforms of NO Synthases , 2000 .

[53]  Marianne Cooper,et al.  Introduction and overview , 1988, J. Am. Soc. Inf. Sci..